Pandemi Döneminde Jinekolojik Kanserler ve Meme Kanserinin Erken Tanınması ve Tarama Testleri: Kadınlar Ne Düşünüyor?

Yıl 2022, , 499 - 505, 01.09.2022

Çiğdem Gün Kakaşçı , Nazife Bakır , Cuma Demir

https://doi.org/10.26453/otjhs.1138556

Öz

Amaç: Çalışma pandemi döneminde jinekolojik kanserler ve meme kanserinin erken tanınması ve tarama testleri hakkında kadınların görüşlerini belirlemek amacıyla tanımlayıcı ve kesitsel tipte gerçekleştirilmiştir.

Materyal ve Metot: Çalışma tanımlayıcı ve kesitsel tipte planlanmıştır. Veri toplama formu olarak araştırmacıların literatür taraması yaparak oluşturduğu tanıtıci bilgi formu kullanılmıştır.

Bulgular: Çalışma kriterlerine uyan 220 kadınla tamamlanan çalışmada katılımcıların yarısından fazlası cinsel bölge veya karın bölgesinde ağrı (%56,4), anormal vajinal kanama (%63,2), idrar yapmada zorlanma (%54,5), cinsel ilişki sırasında ağrı duyma (%55), meme başında çökme, renk değişikliği, şekil bozukluğu (%66,8), meme başında kızarıklık /yara (%61,4) ve uzun süreli sırt ağrısı (%54,5) gibi kanser belirtileri olabilecek durumlarla karşılaşsa bile pandemi nedeniyle doktora gitmeyeceğini bildirmiştir. %71,4’ü jinekolojik kontrollerini yaptırmak istemediğini, %69,5’i rahim ağzı kanser tarama testlerini yaptırmak istemediğini, %59,5’i mamografi ve klinik meme muayenesi yaptırmak istemediğini bildirmiştir.

Sonuç: Pandemi sırasında kadınların çoğu, potansiyel meme kanseri ve jinekolojik kanser semptomları yaşamaları durumunda sağlık hizmetlerinden kaçınmayı tercih etmektedir. 

Anahtar Kelimeler

Tarama testleri, kanser, jinekoloji, meme kanseri, COVID-19

Destekleyen Kurum

yoktur

Proje Numarası

yoktur

Teşekkür

yoktur

Early Detection of Gynecological Cancers and Breast Cancer During the Pandemic and Screening Tests: What Do Women Think?

Öz

Objective: This descriptive and cross-sectional study was conducted to determine women’s opinions about screening tests and early detection of gynecological cancers and breast cancer during the pandemic.

Materials and Methods: In this descriptive and cross-sectional study, a descriptive information form developed by the researchers through a literature review was used to collect data.

Results: The study was conducted with 220 women who met the study criteria. More than half of the participants reported that they would not visit the doctor due to the pandemic even if they were faced with conditions that might be the indicators of cancer such as pain in the genital or abdominal region (56.4%), abnormal vaginal bleeding (63.2%), difficulty urinating (54.5%), pain during sexual intercourse (55%), collapsed, discolored or deformed nipples (66.8%), redness / sore on the nipple (61.4%) and long-term back pain (54.5%). Of them, 71.4% did not want to have gynecological controls, 69.5% did not want to have cervical cancer screening tests, and 59.5% did not want to have mammography and clinical breast examination.

Conclusion: During the pandemic, most women choose to avoid healthcare if they experience potential breast cancer and gynecological cancer symptoms. 

Anahtar Kelimeler

Screening tests, cancer, gynecology, breast cancer, COVID-19

Proje Numarası

yoktur

Kaynakça

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382:1708-1720. doi:10.1056/NEJMoa2001017
• Wang CJ, Ng CY, Brook RH. Response to COVID-19 in Taiwan: big data analytics, new technology, and proactive testing. JAMA. 2020;323(14):1341-1342. doi:10.1001/jama.2020.3151
• American Cancer Society. Common questions about the new coronavirus outbreak. https://www.cancer.org/latest-news/common-questions-about-the-new-coronavirus-outbreak.html. Accessed April 26, 2020.
• Janda M, Paul C, Horsham C. Changes in cancer preventive behaviours, screening and diagnosis during COVID-19. Psychooncology. 2020;30(2):271-273.  doi:10.1002/pon.5575
• Quinn-Scoggins HD, Cannings-John R, Moriarty Y, et al. Cancer symptom experience and help-seeking behaviour during the COVID-19 pandemic in the UK: a cross-sectional population survey. BMJ Open. 2021;11(9):e053095. doi:10.1136/bmjopen-2021-053095
• Jones D, Neal RD, Duffy SR, Scott, SE, Whitaker KL, Brain K. Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer: the view from primary care. The Lancet Oncology. 2020;21(6):748-750. doi:10.1016/S1470-2045(20)30242-4
• Cancer Research UK. How coronavirus is impacting cancer services in the UK. 2020. https://scienceblog.cancerresearchuk.org/2020/04/21/how-coronavirus-is-impacting-cancer-services-in-the-uk/. Accessed June 2, 2021.
• IQVIA. Shifts in healthcare demand, delivery and care during the COVID-19 era. https://www.iqvia.com/insights/the-iqvia-institute/covid-19/shifts-in-healthcare-demand-delivery-and-care-during-the-covid-19-era. Accessed June 2, 2021.
• Australian Instiute of Health and Welfare (AIHW). Cancer Screening and COVID-19 in Australia. Cat. No: CAN 136. Canberra, Australia: AIHW; 2020. https://www.aihw.gov.au/reports/cancer-screening/cancer-screening-and-covid-19-in-australia-inbrief/contents/what-was-the-impact-of-covid-19-in-australia. Accessed June 2, 2021.
• Medscape. Three months of COVID19 may mean 80,000 missed cancer diagnoses. https://www.medscape.com/viewarticle/929986.  Accessed January 14, 2021.
• Wernli KJ, Hubbard RA, Johnson E, et al. Patterns of colorectal cancer screening uptake in newly eligible men and women. Cancer Epidemiology and Prevention Biomarkers. 2014;23(7):1230-1237. doi:10.1158/1055-9965.EPI-13-1360
• US Preventive Services Task Force. Final recommendation statement. Breast cancer: screening. https://www.uspreventiveservicestaskforce.org/uspstf/draft-update-summary/breast-cancer-screening1. Accessed May 14, 2021.
• Wilson R, Quinn-Scoggins H, Moriarty Y, et al. Intentions to participate in cervical and colorectal cancer screening during the COVID-19 pandemic: A mixed-methods study. Preventive Medicine. 2021;153:106826. doi:10.1016/j.ypmed.2021.106826
• Özen B, Zincir H, Erten ZK, Özkan F, Elmalı F. Genç kadınların meme kanseri ve kendi kendine meme muayenesi konusunda bilgi ve tutumları ile sağlıklı yaşam biçimi davranışları. Meme Sağlığı Dergisi. 2013;9(4):200-204. doi:10.5152/tjbh.2013.33
• Ali SF, Ayub S, Manzoor NF, et al. Knowledge and awareness about cervical cancer and its prevention amongst interns and nursing staff in tertiary care hospitals in Karachi, Pakistan. Plos One. 2010;5(6):e11059. doi:10.1371/journal.pone.0011059
• Dal NA, Ertem G. Jinekolojik kanserler farkındalık ölçeği geliştirme çalışması. Itobiad: Journal of The Human & Social Science Researches. 2017;6(5):2351-2367.
• Gozum S, Karayurt Ö, Aydın I. Meme kanseri taramalarında champion sağlık inanç modeli ölçeğinin Türkçe uyarlamalarına ilişkin sonuçlar. Hemşirelikte Araştırma Geliştirme Dergisi. 2004;6(1):71-85.
• Durmaz S, Ozvurmaz S, Adana F, Kurt F. Kadınlarda serviks kanserinin tanısına ilişkin tutum ve düzenli jinekolojik muayene ilişkisinin kesitsel olarak değerlendirilmesi. Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi. 2021;5(1):26-36. doi:10.46237/amusbfd.727999
• Kulakçı Altıntaş H, Korkmaz Aslan G. Kadınların meme ve serviks kanserinin erken tanısına yönelik sağlık inançlarının değerlendirilmesi. Hacettepe Üniversitesi Hemşirelik Fakültesi Dergisi. 2020;7(3):249-261. doi:10.31125/hunhemsire.834101
• Açıkgöz A, Çehreli R, Ellidokuz H. Kadınların kanser konusunda bilgi ve tutumları ile erken tanı yöntemlerine yönelik davranışları. Dokuz Eylül Üniversitesi Tıp Fakültesi Dergisi. 2011;25(3):145-154.
• NHS Digital. Appointments in general practice september 2019. https://digital.nhs.uk/data-and-information/publications/statistical/appointments-in-general-practice/september-2019. Accessed May 14, 2021.
• Maringe C, Spicer J, Morris M, et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study. The Lancet Oncology. 2020;21(8):1023–34. doi:10.1016/S1470-2045(20)30388-0
• Petrova D, Pollán M, Rodriguez-Barranco M, Garrido D, Borrás JM, Sánchez MJ. Anticipated help-seeking for cancer symptoms before and after the coronavirus pandemic: results from the onco-barometer population survey in Spain. British Journal of Cancer. 2021;124(12):2017-2025. doi:10.1038/s41416-021-01382-1
• Kirkegaard P, Edwards A, Andersen B. Balancing risks: qualitative study of attitudes, motivations and intentions about attending for mammography during the COVID-19 pandemic. Scandinavian Journal of Public Health. 2021;49(7):700-706. doi:10.1177/14034948211002648
• Miller MM, Meneveau MO, Rochman CM, et al. Impact of the COVID-19 pandemic on breast cancer screening volumes and patient screening behaviors. Breast Cancer Research and Treatment. 2021;189(1):237-246. doi:10.1007/s10549-021-06252-1
• Knoll K, Reiser E, Leitner K, et al. The impact of COVID-19 pandemic on the rate of newly diagnosed gynecological and breast cancers: a tertiary center perspective. Archives of Gynecology and Obstetrics. 2022;305(4):945-953. doi:10.1007/s00404-021-06259-5
• Mast C, del Rio AM. Delayed cancer screenings—a second look. Epic Health Research Network 2020. https://epicresearch.org/articles/delayed-cancer-screenings-a-second-look/. Accessed January 06, 2022.
• Tsibulak I, Reiser E, Bogner G, et al. Decrease in gynecological cancer diagnoses during the COVID-19 pandemic: an Austrian perspective. International Journal of Gynecologic Cancer. 2020;30(11):1667–1671. doi:10.1136/ijgc-2020-001975